QuidelOrtho Corporation (QDEL)
NASDAQ: QDEL · Real-Time Price · USD
29.75
+0.83 (2.87%)
Sep 16, 2025, 12:32 PM EDT - Market open
QuidelOrtho Revenue
QuidelOrtho had revenue of $613.90M in the quarter ending June 29, 2025, a decrease of -3.63%. This brings the company's revenue in the last twelve months to $2.74B, down -3.28% year-over-year. In the year 2024, QuidelOrtho had annual revenue of $2.78B, down -7.17%.
Revenue (ttm)
$2.74B
Revenue Growth
-3.28%
P/S Ratio
0.71
Revenue / Employee
$415,394
Employees
6,600
Market Cap
2.02B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 29, 2024 | 2.78B | -214.90M | -7.17% |
Dec 31, 2023 | 3.00B | -268.20M | -8.21% |
Jan 1, 2023 | 3.27B | 1.57B | 92.28% |
Jan 2, 2022 | 1.70B | 36.90M | 2.22% |
Jan 3, 2021 | 1.66B | 1.13B | 210.66% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
QDEL News
- 19 days ago - QuidelOrtho to Participate in the Baird 2025 Global Healthcare Conference - PRNewsWire
- 25 days ago - QuidelOrtho Completes Debt Refinancing - PRNewsWire
- 26 days ago - Science Bytes Podcast Explores How Diagnostics Can Help Protect Students and Communities - PRNewsWire
- 27 days ago - QuidelOrtho Welcomes Erich Wolff as Executive Vice President, Strategy & Corporate Development - PRNewsWire
- 4 weeks ago - QuidelOrtho Launches Certified Analyzer Program - PRNewsWire
- 5 weeks ago - QuidelOrtho Corporation (QDEL) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - QuidelOrtho Reports Second Quarter 2025 Financial Results - PRNewsWire
- 6 weeks ago - QuidelOrtho Recognized with Three Awards in 2025 IMV ServiceTrak™ - PRNewsWire